Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study

R. Sharon Chinthrajah(Stanford University), Natasha Purington(Stanford University), Sandra Andorf(Stanford University), Andrew Long(Stanford University), Katherine O'Laughlin(Stanford University), Shu Chen Lyu(Stanford University), Monali Manohar(Stanford University), Scott D. Boyd(Stanford University), Robert Tibshirani(Stanford University), Holden T. Maecker(Stanford University), Marshall Plaut(National Institute of Allergy and Infectious Diseases), Kaori Mukai(Stanford University), Mindy Tsai(Stanford University), Manisha Desai(Stanford University), Stephen J. Galli(Stanford University), Kari C. Nadeau(Stanford University)
The Lancet
September 12, 2019
Cited by 317Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis